Psyence Biomedical Ltd Common Shares
Quarterly Financials
| Values in thousands | 2023-09-30 |
|---|---|
Revenue | $0 |
EBITDA | -557 |
EBIT | |
Net Income | -647 |
Net Change In Cash | 0 |
Free Cash Flow | -251 |
Cash | 88 |
Basic Shares | 7,694 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | |||
EBITDA | -2,751 | -1,293 | -334 |
EBIT | -2,751 | ||
Net Income | -51,159 | 8,014 | 8,230 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -2,951 | -519 | -839 |
Cash | 762 | 128 | 648 |
Basic Shares | 6,517 | 5,000 | 32,674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2023-09-30 | -$6.31 |
2023-06-30 | -$0.58 |
2023-03-31 | -$0.16 |
2022-12-31 | $5.16 |
